Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MBII

Marrone Bio Innovations (MBII) Stock Price, News & Analysis

Marrone Bio Innovations logo

About Marrone Bio Innovations Stock (NASDAQ:MBII)

Advanced Chart

Key Stats

Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.55
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Stock News Headlines

Upstream Bio Inc
Upstream Bio Inc (UPB)
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Man shot, killed by Olive Branch SWAT team
See More Headlines

MBII Stock Analysis - Frequently Asked Questions

Marrone Bio Innovations, Inc. (NASDAQ:MBII) released its earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). The basic materials company earned $9.86 million during the quarter, compared to the consensus estimate of $10.79 million. Marrone Bio Innovations had a negative trailing twelve-month return on equity of 70.87% and a negative net margin of 47.07%.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Marrone Bio Innovations investors own include ObsEva (OBSV), Amyris (AMRS), Avino Silver & Gold Mines (ASM), Rexahn Pharmaceuticals (REXN), Plug Power (PLUG), Denali Therapeutics (DNLI) and Palatin Technologies (PTN).

Company Calendar

Last Earnings
11/10/2021
Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural Chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:MBII
CIK
1441693
Fax
N/A
Employees
153
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-47.07%
Pretax Margin
-47.12%
Return on Equity
-70.87%
Return on Assets
-25.23%

Debt

Debt-to-Equity Ratio
0.33
Current Ratio
0.79
Quick Ratio
0.55

Sales & Book Value

Annual Sales
$44.31 million
Price / Sales
3.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
4.69

Miscellaneous

Outstanding Shares
182,378,000
Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:MBII) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners